BioCentury | Feb 15, 2016
Emerging Company Profile

Platelet portrait

...Inc. is developing a technology to isolate exosomes from plasma. ApoCell Inc. has developed its ApoStream...
BioCentury | Aug 7, 2014
Tools & Techniques

Getting personal with CTCs

...sometimes several years," Darren Davis, president and CEO of ApoCell Inc. , told SciBX. ApoCell's ApoStream...
BioCentury | Dec 19, 2013
Translation in Brief

Translational tidbits

...for Cell Therapy and Immunology IZI Diagnostics €4 million ($5.3 million) Partnership to develop ApoCell's ApoStream...
BioCentury | Nov 18, 2013
Company News

ApoCell, Fraunhofer Institute for Cell Therapy and Immunology (IZI) deal

...its ApoCell Europe GmbH European division, which partnered with not-for-profit Fraunhofer IZI to develop ApoCell's ApoStream...
...state of Saxony and €800,000 ($1.1 million) coming from ApoCell. ApoCell will continue to develop ApoStream...
BioCentury | Apr 30, 2012
Clinical News

ApoStream diagnostic data

...Data from blood samples of patients with HCC showed that ApoCell's ApoStream isolated a greater number...
...it plans to deliver ApoStream alpha prototype units to the National Cancer Institute this year. ApoStream...
...Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.) markets Zolinza vorinostat. ApoCell Inc. , Houston, Texas Product: ApoStream...
Items per page:
1 - 5 of 5